You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 24, 2024

SOLTAMOX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Soltamox, and when can generic versions of Soltamox launch?

Soltamox is a drug marketed by Mayne Pharma Commrcl and is included in one NDA.

The generic ingredient in SOLTAMOX is tamoxifen citrate. There are sixteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the tamoxifen citrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Soltamox

A generic version of SOLTAMOX was approved as tamoxifen citrate by ACTAVIS LABS FL INC on February 20th, 2003.

  Sign Up

AI Research Assistant
Sample questions
  • What is the 5 year forecast for SOLTAMOX?
  • What are the global sales for SOLTAMOX?
  • What is Average Wholesale Price for SOLTAMOX?
Drug patent expirations by year for SOLTAMOX
Drug Prices for SOLTAMOX

See drug prices for SOLTAMOX

Recent Clinical Trials for SOLTAMOX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Translational Breast Cancer Research Consortium (TBCRC)Phase 2
Eli Lilly and CompanyPhase 2
Jose Pablo LeonePhase 2

See all SOLTAMOX clinical trials

Pharmacology for SOLTAMOX

US Patents and Regulatory Information for SOLTAMOX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma Commrcl SOLTAMOX tamoxifen citrate SOLUTION;ORAL 021807-001 Oct 29, 2005 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for SOLTAMOX

See the table below for patents covering SOLTAMOX around the world.

Country Patent Number Title Estimated Expiration
Portugal 893121 ⤷  Sign Up
Spain 2174388 ⤷  Sign Up
Germany 69804169 ⤷  Sign Up
European Patent Office 0893121 Solution liquide de médicament pour administration orale (Oral liquid medicine solution) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.